{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:19:00Z","timestamp":1789726740726,"version":"4.0.1"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2013,8,15]],"date-time":"2013-08-15T00:00:00Z","timestamp":1376524800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0072745","type":"journal-article","created":{"date-parts":[[2013,8,16]],"date-time":"2013-08-16T04:28:31Z","timestamp":1376627311000},"page":"e72745","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":66,"title":["Subunit Vaccine Consisting of Multi-Stage Antigens Has High Protective Efficacy against Mycobacterium tuberculosis Infection in Mice"],"prefix":"10.1371","volume":"8","author":[{"given":"Qi","family":"Xin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxia","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingxiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanbo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zejiao","family":"Da","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoyang","family":"Xian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingming","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingdong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,8,15]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.tim.2006.11.008","article-title":"Vaccine strategies against latent tuberculosis infection","volume":"15","author":"P Andersen","year":"2007","journal-title":"Trends Microbiol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1111\/j.1440-1843.2008.01350.x","article-title":"Immunopathogenesis of tuberculosis: Implications for vaccine development","volume":"13","author":"Y Zhang","year":"2008","journal-title":"Respirology"},{"key":"ref3","first-page":"71","article-title":"The global tuberculosis situation and the new control strategy of the World Health Organization","volume":"79","author":"A Kochi","year":"1991","journal-title":"Tubercle"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0140-6736(09)60331-7","article-title":"Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance","volume":"373","author":"A Wright","year":"2009","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(06)69573-1","article-title":"Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa","volume":"368","author":"NR Gandhi","year":"2006","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3201\/eid1303.061400","article-title":"Worldwide emergence of extensively drug-resistant tuberculosis","volume":"13","author":"NS Shah","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(10)60595-8","article-title":"Tuberculosis and HIV: time for an intensified response","volume":"375","author":"TA Ghebreyesus","year":"2010","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/S0140-6736(10)60409-6","article-title":"The HIV-associated tuberculosis epidemic--when will we act?","volume":"375","author":"AD Harries","year":"2010","journal-title":"Lancet"},{"key":"ref9","first-page":"1481","article-title":"Preventive Vaccination Against Tuberculosis with BCG","volume":"24","author":"A Calmette","year":"1931","journal-title":"Proc R Soc Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature","volume":"271","author":"GA Colditz","year":"1994","journal-title":"JAMA"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(06)68507-3","article-title":"Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness","volume":"367","author":"BB Trunz","year":"2006","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in protection by BCG: implications of and for heterologous immunity","volume":"346","author":"PE Fine","year":"1995","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.copbio.2012.03.007","article-title":"Recombinant live vaccine candidates against tuberculosis","volume":"23","author":"SH Kaufmann","year":"2012","journal-title":"Curr Opin Biotechnol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.vaccine.2004.09.008","article-title":"Immunotherapy with fragmented <italic>Mycobacterium tuberculosis<\/italic> cells increases the effectiveness of chemotherapy against a chronical infection in a murine model of tuberculosis","volume":"23","author":"PJ Cardona","year":"2005","journal-title":"Vaccine"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/nm.2420","article-title":"A recombinant <italic>Mycobacterium smegmatis<\/italic> induces potent bactericidal immunity against <italic>Mycobacterium tuberculosis<\/italic>","volume":"17","author":"KA Sweeney","year":"2011","journal-title":"Nat Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1086\/590185","article-title":"Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa","volume":"198","author":"T Hawkridge","year":"2008","journal-title":"J Infect Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e5856","DOI":"10.1371\/journal.pone.0005856","article-title":"Intranasal mucosal boosting with an adenovirus-vectored vaccine markedly enhances the protection of BCG-primed guinea pigs against pulmonary tuberculosis","volume":"4","author":"Z Xing","year":"2009","journal-title":"PLOS ONE"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/QAD.0b013e3283350f1b","article-title":"Prevention of tuberculosis in Bacille Calmette-Guerin-primed, HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine","volume":"24","author":"CF von Reyn","year":"2010","journal-title":"AIDS"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/nm0896-893","article-title":"Immunogenicity and protective efficacy of a tuberculosis DNA vaccine","volume":"2","author":"K Huygen","year":"1996","journal-title":"Nat Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"6622","DOI":"10.1128\/IAI.72.11.6622-6632.2004","article-title":"The protective effect of the <italic>Mycobacterium bovis<\/italic> BCG vaccine is increased by coadministration with the <italic>Mycobacterium tuberculosis<\/italic> 72-kilodalton fusion polyprotein Mtb72F in <italic>M. tuberculosis<\/italic>-infected guinea pigs","volume":"72","author":"L Brandt","year":"2004","journal-title":"Infect Immun"},{"key":"ref21","article-title":"Vaccine development process. Available: http: \/\/www","author":"Aeras","year":"2012"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nm.2285","article-title":"A multistage tuberculosis vaccine that confers efficient protection before and after exposure","volume":"17","author":"C Aagaard","year":"2011","journal-title":"Nat Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"53ra74","DOI":"10.1126\/scitranslmed.3001094","article-title":"A defined tuberculosis vaccine candidate boosts BCG and protects against multidrug-resistant <italic>Mycobacterium tuberculosis<\/italic>","volume":"2","author":"S Bertholet","year":"2010","journal-title":"Sci Transl Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/sj.clpt.6100362","article-title":"Advances in the treatment of tuberculosis","volume":"82","author":"Y Zhang","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.tibs.2003.10.009","article-title":"Resuscitation-promoting factors possess a lysozyme-like domain","volume":"29","author":"M Cohen-Gonsaud","year":"2004","journal-title":"Trends Biochem Sci"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1365-2958.2007.06078.x","article-title":"The resuscitation-promoting factors of <italic>Mycobacterium tuberculosis<\/italic> are required for virulence and resuscitation from dormancy but are collectively dispensable for growth in vitro","volume":"67","author":"BD Kana","year":"2007","journal-title":"Mol Microbiol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1128\/IAI.73.5.3038-3043.2005","article-title":"Mutants of <italic>Mycobacterium tuberculosis<\/italic> lacking three of the five rpf-like genes are defective for growth in vivo and for resuscitation in vitro","volume":"73","author":"KJ Downing","year":"2005","journal-title":"Infect Immun"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1128\/IAI.68.1.214-220.2000","article-title":"Comparative evaluation of low-molecular-mass proteins from <italic>Mycobacterium tuberculosis<\/italic> identifies members of the ESAT-6 family as immunodominant T-cell antigens","volume":"68","author":"RL Skj\u00f8t","year":"2000","journal-title":"Infect Immun"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.4049\/jimmunol.161.5.2356","article-title":"Molecular cloning and immunologic reactivity of a novel low molecular mass antigen of <italic>Mycobacterium tuberculosis<\/italic>","volume":"161","author":"RN Coler","year":"1998","journal-title":"J Immunol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1002\/(SICI)1521-4141(199812)28:12<3949::AID-IMMU3949>3.0.CO;2-4","article-title":"Differential T cell responses to <italic>Mycobacterium tuberculosis<\/italic> ESAT6 in tuberculosis patients and healthy donors","volume":"28","author":"T Ulrichs","year":"1998","journal-title":"Eur J Immunol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.4049\/jimmunol.154.9.4665","article-title":"Mapping of T cell epitopes of the 30-kDa alpha antigen of <italic>Mycobacterium bovis<\/italic> strain bacillus Calmette-Guerin in purified protein derivative (PPD)-positive individuals","volume":"154","author":"RF Silver","year":"1995","journal-title":"J Immunol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S0264-410X(96)00274-5","article-title":"Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex","volume":"15","author":"E Lozes","year":"1997","journal-title":"Vaccine"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"6332","DOI":"10.4049\/jimmunol.174.10.6332","article-title":"Exchanging ESAT6 with TB10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy","volume":"174","author":"J Dietrich","year":"2005","journal-title":"J Immunol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1073\/pnas.92.5.1530","article-title":"Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of <italic>Mycobacterium tuberculosis<\/italic>","volume":"92","author":"MA Horwitz","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"9451","DOI":"10.1016\/j.vaccine.2011.10.032","article-title":"Construction and evaluation of a multistage <italic>Mycobacterium tuberculosis<\/italic> subunit vaccine candidate Mtb10.4-HspX","volume":"29","author":"H Niu","year":"2011","journal-title":"Vaccine"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"6179","DOI":"10.1016\/j.vaccine.2009.08.018","article-title":"Fusion protein Ag85B-MPT64(190-198)-Mtb8.4 has higher immunogenicity than Ag85B with capacity to boost BCG-primed immunity against <italic>Mycobacterium tuberculosis<\/italic> in mice","volume":"27","author":"Y Luo","year":"2009","journal-title":"Vaccine"},{"key":"ref37","article-title":"<italic>Mycobacterium tuberculosis<\/italic> fusion protein and its preparation method and use thereof. International Application No. PCT\/CN2011\/001071","author":"B Zhu","year":"2011"},{"key":"ref38","article-title":"The construction method of a novel <italic>Mycobacterium tuberculosis<\/italic> fusion protein Mtb10.4-Hsp16.3 and its application","author":"B Zhu","year":"2010"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1046\/j.1365-2958.2002.03237.x","article-title":"Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines <italic>Mycobacterium bovis<\/italic> BCG and <italic>Mycobacterium microti<\/italic>","volume":"46","author":"AS Pym","year":"2002","journal-title":"Mol Microbiol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1016\/j.vaccine.2010.02.094","article-title":"Ag85B-ESAT-6 adjuvanted with IC31 promotes strong and long-lived <italic>Mycobacterium tuberculosis<\/italic> specific T cell responses in na\u00efve human volunteers","volume":"28","author":"JT van Dissel","year":"2010","journal-title":"Vaccine"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1365-3083.2011.02531.x","article-title":"Immunogenicity and protective efficacy of a fusion protein vaccine consisting of antigen Ag85B and HspX against <italic>Mycobacterium tuberculosis<\/italic> infection in mice","volume":"73","author":"Q Li","year":"2011","journal-title":"Scand J Immunol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/resp.12052","article-title":"Systems approach to tuberculosis vaccine development","volume":"18","author":"CC Wang","year":"2013","journal-title":"Respirology"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1046\/j.1365-2567.1996.457538.x","article-title":"Dynamic changes in circulating and antigen-responsive T-cell subpopulations post-<italic>Mycobacterium bovis<\/italic> infection in cattle","volume":"87","author":"JM Pollock","year":"1996","journal-title":"Immunology"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2567.2004.02003.x","article-title":"Influence of pathological progression on the balance between cellular and humoral immune responses in <italic>bovine tuberculosis<\/italic>","volume":"114","author":"MD Welsh","year":"2005","journal-title":"Immunology"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1126\/science.280.5368.1432","article-title":"Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency","volume":"280","author":"F Altare","year":"1998","journal-title":"Science"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and Th17 Cells","volume":"27","author":"T Korn","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/ni1449","article-title":"IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during <italic>Mycobacterium tuberculosis<\/italic> challenge","volume":"8","author":"SA Khader","year":"2007","journal-title":"Nat Immunol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1084\/jem.183.6.2593","article-title":"T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines","volume":"183","author":"F Fossiez","year":"1996","journal-title":"J Exp Med"},{"key":"ref49","first-page":"2029","article-title":"IL-17 and IFN-gamma production in peripheral blood following BCG vaccination and <italic>Mycobacterium tuberculosis<\/italic> infection in human","volume":"16","author":"Q Li","year":"2012","journal-title":"Eur Rev Med Pharmacol Sci"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0072745","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T21:55:53Z","timestamp":1688421353000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0072745"}},"subtitle":[],"editor":[{"given":"Pere-Joan","family":"Cardona","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,8,15]]},"references-count":49,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2013,8,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0072745","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,15]]}}}